Cargando…

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

PURPOSE: Iron deficiency anemia (IDA) is common in cancer patients due to blood loss and inflammation. Many do not tolerate oral iron or adequately respond. Intravenous (IV) iron is commonly used as an adjunct to erythropoiesis-stimulating agents; data on the use of IV iron monotherapy in these pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vadhan-Raj, Saroj, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Strauss, William E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724711/ https://www.ncbi.nlm.nih.gov/pubmed/29263710 http://dx.doi.org/10.2147/JBM.S138474

Ejemplares similares

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014)

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
por: Vadhan-Raj, Saroj, et al.
Publicado: (2016)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
por: Ford, David C, et al.
Publicado: (2016)

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
por: Macdougall, Iain C., et al.
Publicado: (2019)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy
por: Gerb, Jesse, et al.
Publicado: (2021)

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
por: Adkinson, N. Franklin, et al.
Publicado: (2018)

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia
por: Strauss, William E., et al.
Publicado: (2016)

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA
por: Dahl, Naomi V, et al.
Publicado: (2017)

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
por: Hetzel, David, et al.
Publicado: (2014)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
por: Adkinson, N Franklin, et al.
Publicado: (2017)

A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients
por: Zuo, Qianwei, et al.
Publicado: (2022)

Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia
por: Acaster, Sarah, et al.
Publicado: (2015)

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review
por: Glaspy, John A, et al.
Publicado: (2020)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemia
por: Kalra, Philip A, et al.
Publicado: (2016)

Efficacy of SXN in the Treatment of Iron Deficiency Anemia: A Phase IV Clinical Trial
por: Ding, Lu, et al.
Publicado: (2019)

Letter to the editor regarding ‘A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients’
por: Li, Linqiang, et al.
Publicado: (2023)

Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020)

Can Double Fortification of Salt with Iron and Iodine Reduce Anemia, Iron Deficiency Anemia, Iron Deficiency, Iodine Deficiency, and Functional Outcomes? Evidence of Efficacy, Effectiveness, and Safety
por: Larson, Leila M, et al.
Publicado: (2021)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
por: Naqash, Amreen, et al.
Publicado: (2018)

Safety and efficacy of a single total dose infusion (1020 mg) of ferumoxytol
por: Khan, Harris, et al.
Publicado: (2021)

Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron
por: Strauss, William E, et al.
Publicado: (2018)

Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia
por: Hussain, Iftikhar, et al.
Publicado: (2013)

Safety and Efficacy of Intravenous Iron Sucrose for Iron-Deficiency Anemia in Children and Adolescents With Inflammatory Bowel Disease
por: Sabe, Ramy, et al.
Publicado: (2019)

Iron deficiency and iron deficiency anemia in pregnancy
por: Malinowski, A. Kinga, et al.
Publicado: (2021)

Oxidation of ferumoxytol by ionizing radiation releases iron. An electron paramagnetic resonance study
por: Petronek, Michael S, et al.
Publicado: (2022)

Iron-Refractory Iron Deficiency Anemia
por: Yılmaz Keskin, Ebru, et al.
Publicado: (2015)

Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
por: Pai, Amy Barton, et al.
Publicado: (2012)

Treating Iron Deficiency (ID) Anemia in Heart Failure (HF) Patients with IV Iron: A Meta-Analysis
por: Ogugua, Fredrick M, et al.
Publicado: (2023)

Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)

The Efficacy and Safety of Vitamin C for Iron Supplementation in Adult Patients With Iron Deficiency Anemia: A Randomized Clinical Trial
por: Li, Nianyi, et al.
Publicado: (2020)

Efficacy and safety of ferric derisomaltose (FDI) compared with iron sucrose (IS) in patients with iron deficiency anemia after bariatric surgery
por: Auerbach, Michael, et al.
Publicado: (2022)

Efficacy of Trikatrayadi Lauha in Panduroga with reference to Iron Deficiency Anemia
por: Khan, Subir Kumar, et al.
Publicado: (2012)

Anemia and Iron Deficiency in Pregnancy
por: Krafft, Alexander, et al.
Publicado: (2012)

Iron Deficiency Anemia in Pregnancy
por: Raut, Akshara K, et al.
Publicado: (2022)

Ferumoxytol across the age spectrum: a single center experience of safety
por: Nguyen, Kim-Lien, et al.
Publicado: (2016)

Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains
por: Theruvath, Ashok Joseph, et al.
Publicado: (2020)

Iron Deficiency and Iron Deficiency Anemia in Children with Febrile Seizure
por: Fallah, R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mjtqbfug8hbthnvea7hndp8c3o